Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa
NCT07689188
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hidradenitis Suppurativa (HS)
Interventions
DRUG:
Roflumilast 0.3% topical foam
Sponsor
Harrison Dermatology